アポトーシスアッセイの世界市場2020-2027:製品別(キット、試薬)、アッセイ種類別(カスパーゼ、DNA断片化)、技術別、最終用途別、地域別

◆英語タイトル:Apoptosis Assay Market Size, Share & Trends Analysis Report By Product (Kits, Reagents), By Assay Type (Caspase, DNA Fragmentation), By Technique, By End Use, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20NV085
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年9月18日
◆ページ数:140
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、アポトーシスアッセイの世界市場について調査・分析し、調査手法・範囲、市場定義、エグゼクティブサマリー、市場要因・動向・範囲、産業概要、ビジネス環境分析、競争分析、製品別市場規模(キット、試薬、道具)、技術別市場規模(フローサイトメトリー、蛍光顕微鏡、分光光度法、その他)、アッセイ種類別市場規模(カスパーゼ、DNA断片化、細胞透過性アッセイ、ミトコンドリアアッセイ)、最終用途別市場規模(製薬・バイオテクノロジー企業、病院・診断研究所、学術・研究所)、地域別市場規模、企業概要などの項目を掲載しています。
・調査手法・範囲
・市場定義
・エグゼクティブサマリー
・市場要因・動向・範囲
・産業概要
・ビジネス環境分析
・競争分析
・アポトーシスアッセイの世界市場規模:製品別(キット、試薬、道具)
・アポトーシスアッセイの世界市場規模:技術別(フローサイトメトリー、蛍光顕微鏡、分光光度法、その他)
・アポトーシスアッセイの世界市場規模:アッセイ種類別(カスパーゼ、DNA断片化、細胞透過性アッセイ、ミトコンドリアアッセイ)
・アポトーシスアッセイの世界市場規模:最終用途別(製薬・バイオテクノロジー企業、病院・診断研究所、学術・研究所)
・アポトーシスアッセイの世界市場規模:地域別
・企業概要
【レポートの概要】

Apoptosis Assay Market Growth & Trends

The global apoptosis assay market size is expected to reach USD 7.5 billion by 2027, expanding at a CAGR of 7.6%, according to a new report by Grand View Research, Inc. Extensive research activities on expanding applications of drug-induced apoptosis assays have propelled the inclination of pharmaceutical manufacturers towards incorporating cell cycle products in the drug discovery and designing process.

The introduction of affordable and easy to perform kits that can be accommodated in complex experiments is expected to minimize the overhead costs of apoptosis experiments. Companies are providing highly precise reagents and lot-to-lot reproducibility in sample measurements.

Professionals at pharmaceutical companies are making use of cell-cycle inhibitors and Apoptosis-Inducing Factors (AIF)/ molecules to explore possible drug targets. Also, high demand for caspase activity assays along with Bcl-2 protein family across pharmaceutical companies for apoptosis detection has been observed in recent years. Biotechnology companies are enhancing quantification techniques to enable real-time monitoring of apoptotic cellular dynamics.

The presence of established guidelines and protocols for cell-potency assays has strengthened the development of efficient cell-death detection assays. Whereas, stringent regulations with respect to the approval of cell-potency assays are ensuring successful uptake of market products launched.

The flow cytometry segment dominated the market and accounted for the largest revenue share in 2019. This is attributed to the increasing adoption of the technique among researchers. It helps in finding the difference between intact mitochondria (healthy cells) and permeabilized mitochondria (cells undergoing death). The segment is anticipated to grow fast over the forecast period.

The pharmaceutical and biotechnology segment dominated the market in 2019 and is anticipated to continue its dominance over the forecast period. This is attributed to the rising incidence of cancer and neurodegenerative disorders. In addition, the growing significance of programmed cell death or apoptosis to treat chronic diseases is driving the segment growth.

Apoptosis Assay Market Report Highlights

• The kits segment dominated the market and accounted for a revenue share of around 50.0% owing to increasing investment by key market players

• Increase in the demand for fluorochrome-labeled inhibitors of caspases has made reagents the fastest growing product segment in the market

• Application of these inhibitors with other techniques is anticipated to enhance the apoptosis assessment, thereby driving segment growth

• Owing to the wide adoption and easy availability of products, flow cytometry is estimated to account for a substantial share of approximately 35.0% in 2019

• The increasing significance of continuous monitoring of programmed cell death across novel drug discoveries and development of advanced therapeutics is set to propel market growth

• North America has dominated the market in terms of revenue share in 2019, and Asia Pacific is expected to witness the fastest growth in the coming years as a result of the expanding CRO landscape in the region

• Key companies are competing in terms of a combination of products and services in order to maintain market share.

【レポートの目次】

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details of Primary Research
1.5 Information or Data Analysis
1.5.1 Data analysis of cell-based assays market
1.5.2 Cell-based assay types addressed by market players
1.5.3 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country-wise market estimation using the bottom-up approach
1.8 Global Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Summary
Chapter 4 Market Variables, Trends & Scope
4.1 Market Segmentation
4.2 Apoptosis Assay Market Lineage Outlook
4.2.1 Parent market outlook
4.2.1.1 Top Innovators Of Cell-Based Assay Industry: Products & Services
4.3 Penetration and Growth Prospect Mapping
Chapter 5 Industry Outlook
5.1 Market Driver Analysis
5.1.1 Role of apoptosis assays in drug discovery
5.1.2 Rising demand for apoptosis pathways among pharmaceutical companies
5.1.2.1 Pharmaceutical Companies And Apoptosis Assay Industry
5.1.3 Advances in detection of apoptosis
5.2 Market Restraint Analysis
5.2.1 Lack of unequivocal information on cell death occurrence
Chapter 6 Business Environment Analysis
6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
6.1.1 Political landscape
6.1.1.1 Strengths
6.1.1.2 Weaknesses
6.1.1.3 Opportunities
6.1.1.4 Threats
6.1.2 Economic landscape
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.1.3 Social landscape
6.1.3.1 Strengths
6.1.3.2 Weaknesses
6.1.3.3 Opportunities
6.1.3.4 Threats
6.1.4 Technology landscape
6.1.4.1 Strengths
6.1.4.2 Weaknesses
6.1.4.3 Opportunities
6.1.4.4 Threats
6.2 Porter’s Five Forces Analysis
6.3 Market entry strategies
Chapter 7 Competitive Analysis
7.1 Market Impact Analysis by Key Participants
7.1.1 Ansoff matrix
7.1.2 Company/Competition Categorization (Primary & Secondary market participants)
7.1.3 Innovators
7.2 Vendor Landscape
7.2.1 List of key suppliers and channel partners
7.3 Public Companies
7.3.1 Market Participant Position Analysis
Chapter 8 Products Business Analysis
8.1 Apoptosis Assay Market: Products Movement Analysis
8.2 Kits
8.2.1 Apoptosis assay kits market estimates and forecasts, 2016 – 2027 (USD Million)
8.3 Reagents
8.3.1 Apoptosis assay reagents market estimates and forecast, 2016 – 2027 (USD Million)
8.4 Instruments
8.4.1 Apoptosis assay instruments market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 9 Technique Business Analysis
9.1 Apoptosis Assay Market: Technique Movement Analysis
9.2 Flow Cytometry
9.2.1 Flow cytometry-based apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
9.3 Fluorescence Microscopy
9.3.1 Fluorescence microscopy-based apoptosis assay market estimates and forecast, 2016 – 2027
9.4 Spectrophotometry
9.4.1 Spectrophotometry-based apoptosis assay market estimates and forecast, 2016 – 2027
9.5 Other Techniques
9.5.1 Other techniques-based apoptosis assay market estimates and forecast, 2016 – 2027
Chapter 10 Assay Type Business Analysis
10.1 Apoptosis Assay Market: Assay Type Movement Analysis
10.2 Caspase Assays
10.2.1 Caspase-based apoptosis assay market estimates and forecast, 2016 – 2027
10.3 DNA Fragmentation Assays
10.3.1 DNA fragmentation-based apoptosis assay market estimates and forecast, 2016 – 2027
10.4 Cell Permeability Assays
10.4.1 Cell permeability-based apoptosis assay market estimates and forecast, 2016 – 2027
10.5 Mitochondrial Assays
10.5.1 Mitochondrial-based apoptosis Assay market estimates and forecast, 2016 – 2027
Chapter 11 End-Use Business Analysis
11.1 Apoptosis Assay Market: End-use Movement Analysis
11.2 Pharmaceutical & Biotechnology Companies
11.2.1 Apoptosis assay market for Pharmaceutical & Biotechnology Companies estimates and forecast, 2016 – 2027 (USD million)
11.3 Hospital & Diagnostic Laboratories
11.3.1 Apoptosis assay market for hospital & diagnostic laboratories estimates and forecast, 2016 – 2027 (USD million)
11.4 Academic & Research Institutes
11.4.1 Apoptosis assay market for Academic & research institutes estimates and forecast, 2016 – 2027 (USD million)
Chapter 12 Regional Business Analysis
12.1 Apoptosis Assay Market: Regional Movement Analysis
12.2 North America
12.2.1 North America apoptosis assay market, SWOT Analysis
12.2.2 North America apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.2.3 The U.S.
12.2.3.1 The U.S. apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.3 Canada
12.3.1.1 Canada apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.4 Europe
12.4.1 Europe apoptosis assay market, SWOT Analysis
12.4.2 Europe apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.4.3 Germany
12.4.3.1 Germany apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.4.4 The U.K.
12.4.4.1 The U.K. apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.4.5 France
12.4.5.1 France apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.4.6 Spain
12.4.6.1 Spain apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.4.7 Italy
12.4.7.1 Italy apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.5 Asia-Pacific
12.5.1 Asia Pacific, SWOT Analysis
12.5.2 Asia Pacific apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.5.3 Japan
12.5.3.1 Japan apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.5.4 China
12.5.4.1 China apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.5.5 India
12.5.5.1 India apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.6 Latin America
12.6.1 Latin America apoptosis assay market, SWOT Analysis
12.6.2 Latin America apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.6.3 Brazil
12.6.3.1 Brazil apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.6.4 Mexico
12.6.4.1 Mexico apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.7 Middle East and Africa
12.7.1 Middle East & Africa (MEA) apoptosis assay market, SWOT Analysis
12.7.2 MEA apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.7.3 South Africa
12.7.3.1 South Africa apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
12.7.4 Saudi Arabia
12.7.4.1 Saudi Arabia apoptosis assay market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 13 COMPANY PROFILEs
13.1 Company Profiles
13.1.1 Bio-Techne
13.1.1.1 Company overview
13.1.1.2 Financial Performance
13.1.1.3 Product benchmarking
13.1.2 Biotium
13.1.2.1 Company overview
13.1.2.2 Product benchmarking
13.1.3 GeneCopoeia, Inc.
13.1.3.1 Company overview
13.1.3.2 Product benchmarking
13.1.4 Becton, Dickinson & Company (BD)
13.1.4.1 Company overview
13.1.4.2 Financial performance
13.1.4.3 Product benchmarking
13.1.5 Thermo Fisher Scientific, Inc.
13.1.5.1 Company overview
13.1.5.2 Financial performance
13.1.5.3 Product benchmarking
13.1.6 Promega Corporation
13.1.6.1 Company overview
13.1.6.2 Product benchmarking
13.1.7 Sartorius AG
13.1.7.1 Company overview
13.1.7.2 Financial performance
13.1.7.3 Product benchmarking
13.1.8 Merck KGaA
13.1.8.1 Company overview
13.1.8.2 Sigma-Aldrich, Inc.
13.1.8.2.1 Company overview
13.1.8.3 Merck Millipore
13.1.8.3.1 Company overview
13.1.8.4 Financial performance
13.1.8.5 Product benchmarking
13.1.9 Abcam plc.
13.1.9.1 Company overview
13.1.9.2 Financial performance
13.1.9.3 Product benchmarking
13.1.10 Takara Bio Inc.
13.1.10.1 Company overview
13.1.10.2 Financial performance
13.1.10.3 Product benchmarking
13.1.11 Bio-Rad Laboratories
13.1.11.1 Company overview
13.1.11.2 Financial performance
13.1.11.3 Product benchmarking
13.1.12 Creative Bioarray
13.1.12.1 Company overview
13.1.12.2 Financial performance
13.1.12.3 Product benchmarking


List of Tables

Table 1 List of secondary sources
Table 2 Top innovators of cell-based assay industry
Table 3 Commercially developed apoptosis assay kits by local players in the market
Table 4 Commercial apoptosis assay reagent offerings (excluded from the kit), Novus Biologicals
Table 5 Apoptosis assay kits manufactured by Life Technologies Corporation that are compatible with Attune acoustic focusing cytometer
Table 6 Snapshot of commercially developed apoptosis assays and probes designed for fluorescence imaging/ microscopy
Table 7 Commercially available caspase-based apoptosis assay products: Promega Corporation
Table 8 Commercially manufactured DNA fragmentation-based apoptosis assay products: Emerging & well-established companies
Table 9 Commercially manufactured DNA fragmentation-based apoptosis assay products: Emerging & well-established companies
Table 10 Market participants in this segment and associated product offerings
Table 11 North America apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 12 North America apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 13 North America apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 14 North America apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 15 The U.S. apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 16 The U.S. apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 17 The U.S. apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 18 The U.S. apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 19 Canada apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 20 Canada apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 21 Canada apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 22 Canada apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 23 Europe apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 24 Europe apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 25 Europe apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 26 Europe apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 27 Germany apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 28 Germany apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 29 Germany apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 30 Germany apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 31 The U.K. apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 32 The U.K. apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 33 The U.K. apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 34 The U.K. apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 35 France apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 36 France apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 37 France apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 38 France apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 39 Spain apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 40 Spain apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 41 Spain apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 42 Spain apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 43 Italy apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 44 Italy apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 45 Italy apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 46 Italy apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 47 Asia Pacific apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 48 Asia Pacific apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 49 Asia Pacific apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 50 Asia Pacific apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 51 Japan apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 52 Japan apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 53 Japan apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 54 Japan apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 55 China apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 56 China apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 57 China apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 58 China apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 59 India apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 60 India apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 61 India apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 62 India apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 63 Latin America apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 64 Latin America apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 65 Latin America apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 66 Latin America apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 67 Brazil apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 68 Brazil apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 69 Brazil apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 70 Brazil apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 71 Mexico apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 72 Mexico apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 73 Mexico apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 74 Mexico apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 75 MEA apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 76 MEA apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 77 MEA apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 78 MEA apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 79 South Africa apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 80 South Africa apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 81 South Africa apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 82 South Africa apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 83 Saudi Arabia apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 84 Saudi Arabia apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 85 Saudi Arabia apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 86 Saudi Arabia apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 End-use landscape: Apoptosis assay product penetration
Fig. 5 Data analysis of cell-based assays market
Fig. 6 Cell-based assay types addressed by market players
Fig. 7 Market research approaches
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modeling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Apoptosis Assay market snapshot
Fig. 12 Apoptosis Assay Market Segmentation
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Apoptosis Assay market driver impact
Fig. 15 Apoptosis Assay market restraint impact
Fig. 16 Porter’s Five Forces Analysis
Fig. 17 Factors impacting market entry strategies
Fig. 18 Ansoff Matrix
Fig. 19 Competition Categorization
Fig. 20 Market Participant Revenue Analysis (USD Million): 2019
Fig. 21 Market Participant Gross Profit Analysis (USD Million): 2019
Fig. 22 Apoptosis assay market: Products outlook and key takeaways
Fig. 23 Apoptosis assay market: Products Movement Analysis
Fig. 24 Apoptosis assay kits market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 25 Apoptosis assay reagents market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 26 Apoptosis assay instruments market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 27 Apoptosis assay market: Technique outlook and key takeaways
Fig. 28 Apoptosis assay market: Technique movement analysis
Fig. 29 Flow cytometry-based apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 30 Fluorescence microscopy-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 31 Spectrophotometry-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 32 Other Techniques-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 33 Apoptosis Assay market: Assay type outlook and key takeaways
Fig. 34 Apoptosis Assay market: Assay type movement analysis
Fig. 35 Caspase-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 36 DNA fragmentation-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 37 Cell permeability-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 38 Mitochondrial-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 39 Apoptosis assay market: End-use outlook and key takeaways
Fig. 40 Apoptosis assay market: End-use movement analysis
Fig. 41 Apoptosis market for pharmaceutical & biotechnology companies estimates and forecast, 2016 - 2027 (USD million)
Fig. 42 Apoptosis market for hospital & diagnostic laboratories estimates and forecast, 2016 - 2027 (USD Million)
Fig. 43 Apoptosis Market for academic & research institutes estimates and forecast, 2016 - 2027 (USD Million)
Fig. 44 Apoptosis assay market: Regional outlook and key takeaways
Fig. 45 Apoptosis assay market: Regional movement analysis
Fig. 46 North America apoptosis assay market overview
Fig. 47 North America apoptosis assay market, SWOT analysis
Fig. 48 North America apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 49 The U.S.
Fig. 50 The U.S. apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 51 Canada apoptosis assay market overview
Fig. 52 Canada apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 53 Europe apoptosis assay market overview
Fig. 54 Europe apoptosis assay market, SWOT analysis
Fig. 55 Europe apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 56 Germany apoptosis assay market overview
Fig. 57 Germany apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 58 The U.K. apoptosis assay market overview
Fig. 59 The U.K. apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 60 France apoptosis assay market overview
Fig. 61 France apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 62 Spain apoptosis assay market overview
Fig. 63 Spain apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 64 Italy apoptosis assay market overview
Fig. 65 Italy apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 66 Asia Pacific apoptosis assay market overview
Fig. 67 Asia Pacific, SWOT
Fig. 68 Asia Pacific apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 69 Japan apoptosis assay market overview
Fig. 70 Japan apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 71 China apoptosis assay market overview
Fig. 72 China apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 73 India apoptosis assay market overview
Fig. 74 India apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 75 Latin America apoptosis assay market overview
Fig. 76 Latin America apoptosis assay market, SWOT analysis
Fig. 77 Latin America apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 78 Brazil apoptosis assay market overview
Fig. 79 Brazil apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 80 Mexico apoptosis assay market overview
Fig. 81 Mexico apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 82 Middle East & Africa apoptosis assay market overview
Fig. 83 Middle East & Africa apoptosis assay market, SWOT analysis
Fig. 84 MEA apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 85 South Africa apoptosis assay market overview
Fig. 86 South Africa apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 87 Saudi Arabia apoptosis assay market overview
Fig. 88 Saudi Arabia apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アポトーシスアッセイの世界市場2020-2027:製品別(キット、試薬)、アッセイ種類別(カスパーゼ、DNA断片化)、技術別、最終用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆